• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道中的宿主-微生物群相互作用。

Host-microbiota interactions in the intestine.

作者信息

Elson Charles O, Alexander Katie L

出版信息

Dig Dis. 2015;33(2):131-136. doi: 10.1159/000369534. Epub 2015 Apr 22.

DOI:10.1159/000369534
PMID:25925913
Abstract

The comprehensive collection of bacterial species, termed microbiota, within human and other mammalian hosts has profound effects on both innate and adaptive immunity. Multiple host innate mechanisms contribute to intestinal homeostasis, including epithelial production of protective mucin layers maintaining spatial segregation in the intestine as well as epithelial cell secretion of a broad range of antimicrobial peptides. Additionally, epithelial cells employ autophagy to contain and eliminate invading bacteria; interestingly, genetic variants in specific autophagy genes are linked to susceptibility to Crohn's disease. Innate lymphoid cells, which rapidly respond to cytokine and microbial signals, have emerged as important regulators of the intestinal immune response to the microbiota. With regard to adaptive immunity, specific microbial species stimulate induction of regulatory T cells while others induce effector T cells within the gut. Such stimulation is subject to dysregulation during inflammation and disease, contributing to 'dysbiosis' or an abnormal microbiota composition that has been associated with a variety of immune-mediated inflammatory disorders, including celiac disease. The microbiota communicates with the immune system and vice versa; thus, an abnormal microbiota composition likely translates into an altered host immune response, though the exact mechanisms of such are not yet clear. Immunoglobulin A plays a critical role in limiting bacterial access to the host and in maintaining mutualism with the microbiota. Perturbation of the mucosal barrier via infection or other means can induce effector T cells reactive to the intestinal microbiota, and these cells can persist as memory cells for extended periods of time and potentially serve as pathogenic effector cells upon re-encounter with antigen. Health is associated with a diverse microbiota that functions to maintain the balance between T effector and T regulatory cells in the intestine. Whether dysbiosis can be reversed in immune-mediated disease, thus restoring health, is a question of intense interest for this active area of research.

摘要

人类和其他哺乳动物宿主体内的细菌种类综合集合,即微生物群,对先天性免疫和适应性免疫都有深远影响。多种宿主先天性机制有助于肠道稳态,包括上皮细胞产生保护性粘蛋白层以维持肠道内的空间隔离,以及上皮细胞分泌多种抗菌肽。此外,上皮细胞利用自噬来容纳和消除入侵细菌;有趣的是,特定自噬基因的遗传变异与克罗恩病易感性相关。先天性淋巴细胞能快速响应细胞因子和微生物信号,已成为肠道对微生物群免疫反应的重要调节因子。关于适应性免疫,特定微生物种类刺激调节性T细胞的诱导,而其他微生物种类则在肠道内诱导效应性T细胞。这种刺激在炎症和疾病期间会失调,导致“生态失调”或微生物群组成异常,这与包括乳糜泻在内的多种免疫介导的炎症性疾病有关。微生物群与免疫系统相互作用;因此,微生物群组成异常可能转化为宿主免疫反应改变,尽管其确切机制尚不清楚。免疫球蛋白A在限制细菌进入宿主以及维持与微生物群的共生关系方面起着关键作用。通过感染或其他方式破坏黏膜屏障可诱导对肠道微生物群有反应的效应性T细胞,这些细胞可作为记忆细胞长期存在,并可能在再次接触抗原时充当致病效应细胞。健康与多样化的微生物群有关,该微生物群的功能是维持肠道内效应性T细胞和调节性T细胞之间的平衡。在免疫介导的疾病中生态失调是否可以逆转从而恢复健康,是这个活跃研究领域备受关注的问题。

相似文献

1
Host-microbiota interactions in the intestine.肠道中的宿主-微生物群相互作用。
Dig Dis. 2015;33(2):131-136. doi: 10.1159/000369534. Epub 2015 Apr 22.
2
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
3
The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.益生菌组合VSL#3对小鼠进行广谱抗生素治疗后的黏膜、外周和全身免疫具有调节作用。
Front Cell Infect Microbiol. 2017 May 5;7:167. doi: 10.3389/fcimb.2017.00167. eCollection 2017.
4
Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.固有淋巴细胞在肠道稳态和炎症性肠病中的作用。
Int J Mol Sci. 2021 Jul 16;22(14):7618. doi: 10.3390/ijms22147618.
5
Immunopathology of inflammatory bowel disease.炎症性肠病的免疫病理学。
World J Gastroenterol. 2014 Jan 7;20(1):6-21. doi: 10.3748/wjg.v20.i1.6.
6
Adaptive immune education by gut microbiota antigens.肠道微生物抗原的适应性免疫教育。
Immunology. 2018 May;154(1):28-37. doi: 10.1111/imm.12896. Epub 2018 Feb 8.
7
Immune and genetic gardening of the intestinal microbiome.肠道微生物群的免疫与基因调控
FEBS Lett. 2014 Nov 17;588(22):4102-11. doi: 10.1016/j.febslet.2014.02.052. Epub 2014 Mar 5.
8
Unconventional immune cells in the gut mucosal barrier: regulation by symbiotic microbiota.肠道黏膜屏障中的非传统免疫细胞:共生微生物群的调节。
Exp Mol Med. 2023 Sep;55(9):1905-1912. doi: 10.1038/s12276-023-01088-9. Epub 2023 Sep 11.
9
Gut Microbiota Modulation on Intestinal Mucosal Adaptive Immunity.肠道微生物群调节肠道黏膜适应性免疫。
J Immunol Res. 2019 Oct 3;2019:4735040. doi: 10.1155/2019/4735040. eCollection 2019.
10
Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.肠道菌群失调驱动的免疫失调促进肝硬化大鼠的屏障破坏和细菌易位。
Hepatology. 2019 Sep;70(3):925-938. doi: 10.1002/hep.30349. Epub 2019 Mar 5.

引用本文的文献

1
Engineering the Future of Regenerative Medicines in Gut Health with Stem Cell-Derived Intestinal Organoids.利用干细胞衍生的肠道类器官打造肠道健康再生医学的未来。
Stem Cell Rev Rep. 2025 May 17. doi: 10.1007/s12015-025-10893-w.
2
Immune pathogenesis of idiopathic granulomatous mastitis: from etiology toward therapeutic approaches.特发性肉芽肿性乳腺炎的免疫发病机制:从病因到治疗方法。
Front Immunol. 2024 Mar 11;15:1295759. doi: 10.3389/fimmu.2024.1295759. eCollection 2024.
3
The role of intestinal microecology in inflammatory bowel disease and colorectal cancer: A review.
肠道微生态在炎症性肠病和结直肠癌中的作用:综述。
Medicine (Baltimore). 2023 Dec 22;102(51):e36590. doi: 10.1097/MD.0000000000036590.
4
The potential application of probiotics for the prevention and treatment of COVID-19.益生菌在预防和治疗新型冠状病毒肺炎中的潜在应用。
Egypt J Med Hum Genet. 2022;23(1):36. doi: 10.1186/s43042-022-00252-6. Epub 2022 Mar 25.
5
Microbial sensing in the intestine.肠道中的微生物感应。
Protein Cell. 2023 Nov 8;14(11):824-860. doi: 10.1093/procel/pwad028.
6
Commensal microbiota modulates phenotypic characteristics and gene expression in piglet Peyer's patches.共生微生物群调节仔猪派尔集合淋巴结的表型特征和基因表达。
Front Physiol. 2023 Mar 22;14:1084332. doi: 10.3389/fphys.2023.1084332. eCollection 2023.
7
The Role of Gut Bacteriome in Asthma, Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea.肠道微生物群在哮喘、慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停中的作用。
Microorganisms. 2022 Dec 13;10(12):2457. doi: 10.3390/microorganisms10122457.
8
Aspects Towards the Anastomotic Healing in Crohn's Disease: Clinical Approach and Current Gaps in Research.克罗恩病吻合口愈合的相关方面:临床方法与当前研究空白
Front Surg. 2022 Jun 24;9:882625. doi: 10.3389/fsurg.2022.882625. eCollection 2022.
9
The Complex Link and Disease Between the Gut Microbiome and the Immune System in Infants.婴儿肠道微生物组与免疫系统之间的复杂联系和疾病。
Front Cell Infect Microbiol. 2022 Jun 15;12:924119. doi: 10.3389/fcimb.2022.924119. eCollection 2022.
10
The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota.芪白平肺胶囊治疗慢性阻塞性肺疾病可能通过 Th17/Treg 平衡和肠-肺轴微生物群介导。
J Transl Med. 2022 Jun 21;20(1):281. doi: 10.1186/s12967-022-03481-w.